These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8939877)

  • 1. A strategy for designing inhibitors of beta-amyloid toxicity.
    Ghanta J; Shen CL; Kiessling LL; Murphy RM
    J Biol Chem; 1996 Nov; 271(47):29525-8. PubMed ID: 8939877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF.
    Lowe TL; Strzelec A; Kiessling LL; Murphy RM
    Biochemistry; 2001 Jul; 40(26):7882-9. PubMed ID: 11425316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.
    Hughes E; Burke RM; Doig AJ
    J Biol Chem; 2000 Aug; 275(33):25109-15. PubMed ID: 10825171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of toxicity and protofibril formation in the amyloid-beta peptide beta(25-35) using N-methylated derivatives.
    Doig AJ; Hughes E; Burke RM; Su TJ; Heenan RK; Lu J
    Biochem Soc Trans; 2002 Aug; 30(4):537-42. PubMed ID: 12196132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.
    Pallitto MM; Ghanta J; Heinzelman P; Kiessling LL; Murphy RM
    Biochemistry; 1999 Mar; 38(12):3570-8. PubMed ID: 10090743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
    Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
    ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ
    Alghazwi M; Smid S; Musgrave I; Zhang W
    Neurochem Int; 2019 Mar; 124():215-224. PubMed ID: 30639263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cannabis flavonoid, cannflavin A displays both a hormetic and neuroprotective profile against amyloid β-mediated neurotoxicity in PC12 cells: Comparison with geranylated flavonoids, mimulone and diplacone.
    Eggers C; Fujitani M; Kato R; Smid S
    Biochem Pharmacol; 2019 Nov; 169():113609. PubMed ID: 31437460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
    Cottingham MG; Hollinshead MS; Vaux DJ
    Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sulfated proteoglycan aggregation factor mediates amyloid-beta peptide fibril formation and neurotoxicity.
    McLaurin J; Franklin T; Kuhns WJ; Fraser PE
    Amyloid; 1999 Dec; 6(4):233-43. PubMed ID: 10611943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure.
    Kokkoni N; Stott K; Amijee H; Mason JM; Doig AJ
    Biochemistry; 2006 Aug; 45(32):9906-18. PubMed ID: 16893191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted control of kinetics of beta-amyloid self-association by surface tension-modifying peptides.
    Kim JR; Gibson TJ; Murphy RM
    J Biol Chem; 2003 Oct; 278(42):40730-5. PubMed ID: 12917437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex.
    Son G; Lee BI; Chung YJ; Park CB
    Acta Biomater; 2018 Feb; 67():147-155. PubMed ID: 29221856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new distyrylbenzene-derivative amyloid-β-aggregation and fibril formation inhibitor.
    Suzuki H; Ishigami A; Orimoto A; Matsuyama A; Handa S; Maruyama N; Yokoyama Y; Okuno H; Nakakoshi M
    Chem Pharm Bull (Tokyo); 2012; 60(9):1164-70. PubMed ID: 22976325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation.
    Liu Y; Pukala TL; Musgrave IF; Williams DM; Dehle FC; Carver JA
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6336-40. PubMed ID: 24157371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol reduces amyloid aggregation in vitro and prevents toxicity in cell lines.
    Ormeño D; Romero F; López-Fenner J; Avila A; Martínez-Torres A; Parodi J
    Arch Med Res; 2013 Jan; 44(1):1-7. PubMed ID: 23291379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity.
    Aksenov MY; Aksenova MV; Carney JM; Butterfield DA
    Neurosci Lett; 1996 Oct; 217(2-3):117-20. PubMed ID: 8916086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo design of self-assembled hexapeptides as β-amyloid (Aβ) peptide inhibitors.
    Wang Q; Liang G; Zhang M; Zhao J; Patel K; Yu X; Zhao C; Ding B; Zhang G; Zhou F; Zheng J
    ACS Chem Neurosci; 2014 Oct; 5(10):972-81. PubMed ID: 25133634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.